Possible Involvement of NO-sGC-cGMP Signaling in the Antidepressant Like Effect of Pyridoxine in Mice

Overview

Journal Metab Brain Dis

Publisher Springer

Specialties Endocrinology
Neurology

Date 2021 Nov 5

PMID 34739660

Authors

Sushma Maratha

Vijay Sharma

Vaibhav Walia

Affiliations

Soon will be listed here.

Abstract

The present study was designed to determine the antidepressant like effect of pyridoxine in mice. Pyridoxine (12.5, 25 and 50 mg/kg, i.p.) was administered to the mice and depression related behavioral and neurochemical alterations were determined. It was observed that pyridoxine (50 mg/kg, i.p.) treatment decreased the immobility period in tail suspension test (TST) and forced swim test (FST) significantly as compared to control. Pyridoxine (50 mg/kg, i.p.) treatment increased the level of serotonin (5-HT) and decreased the level of nitrite in the brain of mice significantly as compared to control. Pyridoxine thus confer antidepressant like effect by increasing the level of 5-HT and by decreasing the level of nitrite in the brain of mice. Further the influence of nitric oxide (NO)/ soluble guanylate cyclase (sGC)/ cyclic guanosine monophosphate (cGMP) in antidepressant-like effect of pyridoxine was studied. It was observed that the pretreatment of NO donor (i.e. L-Arginine) and cGMP modulator (i.e. sildenafil) counteracted while the pretreatment of NO/sGC inhibitor (i.e. methylene blue) potentiated the effect of pyridoxine in TST and FST. Pretreatment of NO donor did not influence, pretreatment of NO/sGC inhibitor decreased while the pretreatment of cGMP modulator increased the level of brain nitrite in pyridoxine treated mice. Further the pretreatment of NO donor and cGMP modulator decreased while the pretreatment of NO/sGC inhibitor increased the level of brain serotonin in pyridoxine treated mice. Pyridoxine thus exerted antidepressant like effect and NO-sGC-cGMP signaling modulated the antidepressant like effect of pyridoxine in mice.

References

Almeida R, Felisbino C, Lopez M, Rodrigues A, Gabilan N . Evidence for the involvement of L-arginine-nitric oxide-cyclic guanosine monophosphate pathway in the antidepressant-like effect of memantine in mice. Behav Brain Res. 2006; 168(2):318-22. DOI: 10.1016/j.bbr.2005.11.023. View

Assaad H, Zhou L, Carroll R, Wu G . Rapid publication-ready MS-Word tables for one-way ANOVA. Springerplus. 2014; 3:474. PMC: 4153873. DOI: 10.1186/2193-1801-3-474. View

Assaad H, Hou Y, Zhou L, Carroll R, Wu G . Rapid publication-ready MS-Word tables for two-way ANOVA. Springerplus. 2015; 4:33. PMC: 4305362. DOI: 10.1186/s40064-015-0795-z. View

Baldewicz T, Goodkin K, Feaster D, Blaney N, Kumar M, Kumar A . Plasma pyridoxine deficiency is related to increased psychological distress in recently bereaved homosexual men. Psychosom Med. 1998; 60(3):297-308. DOI: 10.1097/00006842-199805000-00016. View

Benkelfat C, Ellenbogen M, Dean P, Palmour R, Young S . Mood-lowering effect of tryptophan depletion. Enhanced susceptibility in young men at genetic risk for major affective disorders. Arch Gen Psychiatry. 1994; 51(9):687-97. DOI: 10.1001/archpsyc.1994.03950090019003. View

Berger M, Gray J, Roth B . The expanded biology of serotonin. Annu Rev Med. 2009; 60:355-66. PMC: 5864293. DOI: 10.1146/annurev.med.60.042307.110802. View

Bhagwagar Z, Rabiner E, Sargent P, Grasby P, Cowen P . Persistent reduction in brain serotonin1A receptor binding in recovered depressed men measured by positron emission tomography with [11C]WAY-100635. Mol Psychiatry. 2004; 9(4):386-92. DOI: 10.1038/sj.mp.4001401. View

Calderon-Guzman D, Hernandez-Islas J, Espitia-Vazquez I, Barragan-Mejia G, Hernandez-Garcia E, Santamaria-Del Angel D . Pyridoxine, regardless of serotonin levels, increases production of 5-hydroxytryptophan in rat brain. Arch Med Res. 2004; 35(4):271-4. DOI: 10.1016/j.arcmed.2004.03.003. View

Chanrion B, Mannoury la Cour C, Bertaso F, Lerner-Natoli M, Freissmuth M, Millan M . Physical interaction between the serotonin transporter and neuronal nitric oxide synthase underlies reciprocal modulation of their activity. Proc Natl Acad Sci U S A. 2007; 104(19):8119-24. PMC: 1876581. DOI: 10.1073/pnas.0610964104. View

10.

Dhir A, Kulkarni S . Involvement of nitric oxide (NO) signaling pathway in the antidepressant action of bupropion, a dopamine reuptake inhibitor. Eur J Pharmacol. 2007; 568(1-3):177-85. DOI: 10.1016/j.ejphar.2007.04.028. View

11.

Dhir A, Kulkarni S . Nitric oxide and major depression. Nitric Oxide. 2011; 24(3):125-31. DOI: 10.1016/j.niox.2011.02.002. View

12.

Ghasemi M, Sadeghipour H, Mosleh A, Sadeghipour H, Mani A, Dehpour A . Nitric oxide involvement in the antidepressant-like effects of acute lithium administration in the mouse forced swimming test. Eur Neuropsychopharmacol. 2007; 18(5):323-32. DOI: 10.1016/j.euroneuro.2007.07.011. View

13.

Green L, Wagner D, Glogowski J, Skipper P, Wishnok J, Tannenbaum S . Analysis of nitrate, nitrite, and [15N]nitrate in biological fluids. Anal Biochem. 1982; 126(1):131-8. DOI: 10.1016/0003-2697(82)90118-x. View

14.

Gupta G, Jia Jia T, Yee Woon L, Chellappan D, Candasamy M, Dua K . Pharmacological Evaluation of Antidepressant-Like Effect of Genistein and Its Combination with Amitriptyline: An Acute and Chronic Study. Adv Pharmacol Sci. 2015; 2015:164943. PMC: 4670631. DOI: 10.1155/2015/164943. View

15.

Ha E, Jung K, Choe B, Bae J, Shin D, Yim S . Fluoxetine increases the nitric oxide production via nuclear factor kappa B-mediated pathway in BV2 murine microglial cells. Neurosci Lett. 2006; 397(3):185-9. DOI: 10.1016/j.neulet.2005.12.022. View

16.

Harkin A, Bruce K, Craft B, Paul I . Nitric oxide synthase inhibitors have antidepressant-like properties in mice. 1. Acute treatments are active in the forced swim test. Eur J Pharmacol. 1999; 372(3):207-13. DOI: 10.1016/s0014-2999(99)00191-0. View

17.

Harkin A, Connor T, Burns M, Kelly J . Nitric oxide synthase inhibitors augment the effects of serotonin re-uptake inhibitors in the forced swimming test. Eur Neuropsychopharmacol. 2004; 14(4):274-81. DOI: 10.1016/j.euroneuro.2003.08.010. View

18.

Heckler I, Boon E . Insights Into Nitric Oxide Modulated Quorum Sensing Pathways. Front Microbiol. 2019; 10:2174. PMC: 6769237. DOI: 10.3389/fmicb.2019.02174. View

19.

Hillhouse T, Porter J . A brief history of the development of antidepressant drugs: from monoamines to glutamate. Exp Clin Psychopharmacol. 2015; 23(1):1-21. PMC: 4428540. DOI: 10.1037/a0038550. View

20.

Jefferys D, Funder J . Nitric oxide modulates retention of immobility in the forced swimming test in rats. Eur J Pharmacol. 1996; 295(2-3):131-5. DOI: 10.1016/0014-2999(95)00655-9. View